Ronac Mamtani, MD, MSCE

Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
Headshot of Ronac Mamtani, MD, MSCE
Penn Medicine Provider

About me

  • Section Chief, Genitourinary Cancers, Hematology-Oncology
  • David J. Vaughn MD Associate Professor in GU Oncology

My education and training

  • Medical School: SUNY Stony Brook School of Medicine
  • Residency: NewYork-Presbyterian/Weill Cornell Medical Center
  • Fellowship: University of Pennsylvania Health System

Reviews

Average Rating

230 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
just a great experience
Anonymous
April 2026
explains things very well and on my level
Anonymous
April 2026
i was impressed with his knowledge .
Anonymous
April 2026
overall competence.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Mamtani is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Mayer M, Seewald N, Babcock A, Homet Moreno B, Ramamurthy C, Li H, Mamtani R. Untreated advanced urothelial carcinoma (aUC) in the modern treatment era: Patterns of care from a decade-long national cohort. , American Society of Clinical Oncology Annual Meeting, Chicago IL., 44: 2026


Subramanian P, Shyamsunder S, Eshaghi K, Mamtani R, Litt HK. Gaps in patient-facing information on artificial intelligence in cancer care: A cross-sectional analysis. , American Society of Clinical Oncology Annual Meeting, Chicago IL., 44: 2026


Martei YM, Chen K, Obasohan M, Mamtani R, Aakhus E, Shulman LN, Hubbard RA, Clark A. Racial disparities and utilization trends of first-line targeted therapies for metastatic breast cancer , JNCI Cancer Spectr: 2026


Litt HK, Wodzinski A, Subramanian P, Donovan M, Vapiwala N, Narayan V, Mei L, Takvorian S, Haas NB, Parikh RB, Mistry R, Mamtani R. OncoEducate: A Pilot Study of Generative AI to Enhance Patient-Clinician Communication in Genitourinary Cancer Care , Oncologist: 2026


Shen J, Linn KA, Clark AS, Mamtani R, Hubbard RA. Missingness in Eligibility Criteria for Target Trial Emulation in EHR With Survival Outcomes , Stat Med, 45: 2026


Litt H, Mehta P, Sahni A, Mamtani R. FDA-authorized oncology artificial intelligence and machine learning devices and their clinical evidence: A cross-sectional analysis , J Cancer Policy, 48: 2026,100743


Galsky MD, Izadmehr S, Yu M, Curtis SD, Douville C, Popoli M, Ptak J, Dobbyn L, Silliman N, Chan KG, Dorff TB, Cetnar JP, O'Neil B, D'Souza A, Mamtani R, Kyriakopoulos CE, Brody R, Sadimin E, Mehrazin R, Chowell D, Sfakianos J, Daneshmand S, Pal SK, Bettegowda C, Kinzler KW, Papadopoulos N, Vogelstein B, Wang Y. Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancer , Proc Natl Acad Sci U S A, 123: 2026,e2533449123


Litt HK, Wodzinski A, Subramanian P, Donovan M, Vapiwala N, Parikh RB, Narayan V, Mei L, Takvorian SU, Balzer Haas N, Mistry R, and Mamtani R. OncoEducate: A pilot study of generative AI to support patient education in GU cancer care. , 2026 American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fran, CA., 44(7): 2026,713


Squires P, Cook EE, Song Y, Wang CY, Zhang A, Seshasayee SM, Rogiers A, Li H, Mamtani R. Treatment Patterns, Disease Recurrence, and Overall Survival in Patients With Muscle-Invasive Bladder Cancer After Radical Cystectomy: A Population-Level Claims-Based Analysis , Clin Genitourin Cancer: 2026


Wang X, Long JB, Rothen J, Huang S, Soulos PR, Goldberg SB, Robinson TJ, Ma S, Mamtani R, Presley CJ, Wang SY, Kunst N, Gross CP, Dinan MA. A Taxonomy for Assessing Real-World Targeted Cancer Therapy Options in the Context of Broad Genomic Profiling , J Natl Compr Canc Netw, 24: 2026,e257131